(S)-Methyl pyrrolidine-3-carboxylate is a chiral, non-natural amino acid derivative featuring a pyrrolidine ring with a methyl ester functional group. It serves as a versatile and crucial chiral building block in pharmaceutical synthesis. Its pyrrolidine scaffold is a privileged structure found in numerous bioactive molecules. This compound is primarily employed as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its applications are notably prominent in the development of drugs targeting the central nervous system (CNS), such as inhibitors of the glycine transporter 1 (GlyT1) for the potential treatment of schizophrenia. The chiral (S)-configuration is often essential for the desired biological activity of the final drug candidates. As a bifunctional synthon containing both a secondary amine and an ester group, it allows for diverse chemical modifications. It is a valuable precursor for preparing more complex heterocyclic systems and peptidomimetics. The compound is typically handled under inert atmosphere due to the sensitivity of the pyrrolidine nitrogen and is commercially available for research and development purposes.